AI-generated summary
The authors studied rats with an experimentally induced allergic rhinitis model and tested red light therapy at 660 nm, applied either locally over the nostrils or systemically to the tail. They report that local treatment reduced mast cell degranulation, certain inflammatory mediators, and some Th2 cytokines, while systemic treatment changed none of the parameters measured. The study was conducted in animals, so the findings may not apply to humans.
- Who or what was studied
- Adult rats in an experimental model of allergic rhinitis induced with ovalbumin
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The study was conducted only in an animal model, and the abstract states that the approach should be tested clinically before any conclusions about human use.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Light-emitting diode, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.